Recombinant BCG expressing the LTAK63 adjuvant increased memory T cells and induced long-lasting protection against
adjuvant
long-term protection
recombinant BCG
tuberculosis
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
04
2023
accepted:
29
06
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Vaccine-induced protection against
Identifiants
pubmed: 37520577
doi: 10.3389/fimmu.2023.1205449
pmc: PMC10374402
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1205449Informations de copyright
Copyright © 2023 Marques-Neto, Trentini, Kanno, Rodriguez and Leite.
Déclaration de conflit d'intérêts
LL has a patent application on the use of rBCG-LTAK63 as a vaccine against Mtb. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Annu Rev Immunol. 2009;27:393-422
pubmed: 19302046
mSphere. 2020 Apr 15;5(2):
pubmed: 32295871
Vaccine. 2003 Jun 20;21(21-22):2782-90
pubmed: 12798618
Front Pediatr. 2019 Aug 27;7:350
pubmed: 31508399
PLoS Pathog. 2011 May;7(5):e1002052
pubmed: 21625591
Immunol Rev. 2006 Jun;211:154-63
pubmed: 16824125
Mucosal Immunol. 2018 May;11(3):668-680
pubmed: 29186108
Front Immunol. 2019 May 03;10:992
pubmed: 31130965
Vaccine. 2018 Sep 5;36(37):5625-5635
pubmed: 30097220
Vaccines (Basel). 2022 May 24;10(6):
pubmed: 35746439
J Infect Dis. 2018 Apr 11;217(9):1491-1503
pubmed: 29373700
Lancet Respir Med. 2020 Jan;8(1):19
pubmed: 31706931
mBio. 2016 Nov 22;7(6):
pubmed: 27879332
Tuberculosis (Edinb). 2008 Sep;88(5):437-43
pubmed: 18590980
J Immunol. 2020 May 1;204(9):2331-2336
pubmed: 32229539
Pediatr Infect Dis J. 2004 Jun;23(6):544-50
pubmed: 15194836
J Immunol. 2007 Oct 15;179(8):5346-57
pubmed: 17911621
Immunol Lett. 2017 Dec;192:52-60
pubmed: 29106984
J Immunol. 2013 Jun 15;190(12):6311-9
pubmed: 23677471
Infect Immun. 2010 Oct;78(10):4187-94
pubmed: 20679438
Mediators Inflamm. 2015;2015:854507
pubmed: 26640327
J Infect Dis. 2011 Oct 1;204(7):1075-85
pubmed: 21881123
Front Microbiol. 2020 Mar 11;11:332
pubmed: 32218774
PLoS One. 2013 Nov 08;8(11):e78639
pubmed: 24250805
Tuberculosis (Edinb). 2014 Sep;94(5):455-61
pubmed: 24993316
Sci Rep. 2017 May 18;7(1):2109
pubmed: 28522873
J Infect Dis. 2014 Dec 15;210(12):1928-37
pubmed: 24943726
J Clin Invest. 2006 Jun;116(6):1514-24
pubmed: 16691294
Hum Vaccin Immunother. 2018;14(11):2786-2801
pubmed: 29913109
Vaccine. 2021 Dec 8;39(50):7253-7264
pubmed: 34602301
Hum Vaccin Immunother. 2020 Mar 3;16(3):673-683
pubmed: 31665996
Immunol Cell Biol. 2019 Aug;97(7):656-663
pubmed: 31127962
J Infect Dis. 2016 Mar 1;213(5):831-9
pubmed: 26494773
Tuberculosis (Edinb). 2016 Mar;97:163-71
pubmed: 26750180